Sunday, April 5, 2026

New Hope for Solid Tumors? Korean Biotech Starts Phase 1 Trial of Targeted Drug

Digmbio secures 12 billion KRW for clinical trials of cancer drug DM5167 and advances treatment for degenerative brain diseases.

Samsung Biologics: How a 56 Billion USD CDMO Leader is Shaping the Future of Biopharmaceuticals

Samsung Biologics is evolving as a leading CDMO, targeting a production capacity of 1.32M liters by 2030 after its spin-off from Bioepis.

Is Canada’s Shift to China a Sign of U.S. Isolation? Discover the Impact of Trump’s Tariffs

Biden's strategy post-Ukraine invasion contained Russia and checked China, while Trump's policies strained U.S. alliances and empowered China.

Tag: KARI

Rice Cooker-Sized Tech, Big Strategic Ambitions in Low Earth Orbit

KARI has developed a cost-effective orbital deorbiting device for space debris removal, enhancing satellite reusability and sustainability.

Top News

- Our Sponsors Ad -

Follow us